Efficacy and safety of febuxostat in elderly female patients
Tomohiro Mizuno,1,2 Takahiro Hayashi,3 Sayo Hikosaka,1 Yuka Shimabukuro,1 Maho Murase,1 Kazuo Takahashi,2 Hiroki Hayashi,2 Yukio Yuzawa,2 Tadashi Nagamatsu,1 Shigeki Yamada3 1Department of Analytical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan; 2Department of Nephrolo...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-09-01
|
| Series: | Clinical Interventions in Aging |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-and-safety-of-febuxostat-in-elderly-female-patients-peer-reviewed-article-CIA |
| _version_ | 1818858091022647296 |
|---|---|
| author | Mizuno T Hayashi T Hikosaka S Shimabukuro Y Murase M Takahashi K Hayashi H Yuzawa Y Nagamatsu T Yamada S |
| author_facet | Mizuno T Hayashi T Hikosaka S Shimabukuro Y Murase M Takahashi K Hayashi H Yuzawa Y Nagamatsu T Yamada S |
| author_sort | Mizuno T |
| collection | DOAJ |
| description | Tomohiro Mizuno,1,2 Takahiro Hayashi,3 Sayo Hikosaka,1 Yuka Shimabukuro,1 Maho Murase,1 Kazuo Takahashi,2 Hiroki Hayashi,2 Yukio Yuzawa,2 Tadashi Nagamatsu,1 Shigeki Yamada3 1Department of Analytical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan; 2Department of Nephrology, School of Medicine, Fujita Health University, Toyoake, Japan; 3Department of Clinical Pharmacy, School of Medicine, Fujita Health University, Toyoake, Japan Background: Maintenance of low serum urate levels is important for the management of gout. Achieving the recommended serum urate levels of less than 6.0 mg/dL is difficult in elderly (65 years of age or older) patients with renal impairment. Xanthine oxidase inhibitors allopurinol and febuxostat are used for this purpose. Although febuxostat had been shown to be efficacious in elderly patients, its safety and efficacy in elderly female patients with hyper­uricemia remain unclear.Objective: The aim of this study was to assess the efficacy and safety of febuxostat in elderly female patients.Methods: We studied a retrospective cohort study. The study included elderly Japanese patients (65 years of age or older) who were treated with febuxostat at Fujita Health University Hospital from January 2012 to December 2013. The treatment goal was defined as achievement of serum urate levels of 6.0 mg/dL or lower within 16 weeks; this was the primary endpoint in the present study. Adverse events of febuxostat were defined as more than twofold increases in Common Terminology Criteria for adverse events scores from baseline. Results: We evaluated 82 patients treated with febuxostat during the observation period and classified them into male (n=53) and female (n=29) groups. The mean time to achievement of the treatment goal was significantly shorter in the female group (53 days) than in the male group (71 days). There were no significant differences in adverse events between the 2 groups.Conclusion: Our findings suggest that the efficacy of febuxostat in elderly female patients is superior to that in elderly male patients and that the safety is equivalent. Keywords: febuxostat, elderly female patients, hyperuricemia |
| first_indexed | 2024-12-19T08:50:46Z |
| format | Article |
| id | doaj.art-1768aac81d2d41b1a06877fd275ceaa3 |
| institution | Directory Open Access Journal |
| issn | 1178-1998 |
| language | English |
| last_indexed | 2024-12-19T08:50:46Z |
| publishDate | 2014-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Interventions in Aging |
| spelling | doaj.art-1768aac81d2d41b1a06877fd275ceaa32022-12-21T20:28:44ZengDove Medical PressClinical Interventions in Aging1178-19982014-09-01Volume 91489149318208Efficacy and safety of febuxostat in elderly female patientsMizuno THayashi THikosaka SShimabukuro YMurase MTakahashi KHayashi HYuzawa YNagamatsu TYamada STomohiro Mizuno,1,2 Takahiro Hayashi,3 Sayo Hikosaka,1 Yuka Shimabukuro,1 Maho Murase,1 Kazuo Takahashi,2 Hiroki Hayashi,2 Yukio Yuzawa,2 Tadashi Nagamatsu,1 Shigeki Yamada3 1Department of Analytical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan; 2Department of Nephrology, School of Medicine, Fujita Health University, Toyoake, Japan; 3Department of Clinical Pharmacy, School of Medicine, Fujita Health University, Toyoake, Japan Background: Maintenance of low serum urate levels is important for the management of gout. Achieving the recommended serum urate levels of less than 6.0 mg/dL is difficult in elderly (65 years of age or older) patients with renal impairment. Xanthine oxidase inhibitors allopurinol and febuxostat are used for this purpose. Although febuxostat had been shown to be efficacious in elderly patients, its safety and efficacy in elderly female patients with hyper­uricemia remain unclear.Objective: The aim of this study was to assess the efficacy and safety of febuxostat in elderly female patients.Methods: We studied a retrospective cohort study. The study included elderly Japanese patients (65 years of age or older) who were treated with febuxostat at Fujita Health University Hospital from January 2012 to December 2013. The treatment goal was defined as achievement of serum urate levels of 6.0 mg/dL or lower within 16 weeks; this was the primary endpoint in the present study. Adverse events of febuxostat were defined as more than twofold increases in Common Terminology Criteria for adverse events scores from baseline. Results: We evaluated 82 patients treated with febuxostat during the observation period and classified them into male (n=53) and female (n=29) groups. The mean time to achievement of the treatment goal was significantly shorter in the female group (53 days) than in the male group (71 days). There were no significant differences in adverse events between the 2 groups.Conclusion: Our findings suggest that the efficacy of febuxostat in elderly female patients is superior to that in elderly male patients and that the safety is equivalent. Keywords: febuxostat, elderly female patients, hyperuricemiahttps://www.dovepress.com/efficacy-and-safety-of-febuxostat-in-elderly-female-patients-peer-reviewed-article-CIAfebuxostatelderly female patientshyperuricemia |
| spellingShingle | Mizuno T Hayashi T Hikosaka S Shimabukuro Y Murase M Takahashi K Hayashi H Yuzawa Y Nagamatsu T Yamada S Efficacy and safety of febuxostat in elderly female patients Clinical Interventions in Aging febuxostat elderly female patients hyperuricemia |
| title | Efficacy and safety of febuxostat in elderly female patients |
| title_full | Efficacy and safety of febuxostat in elderly female patients |
| title_fullStr | Efficacy and safety of febuxostat in elderly female patients |
| title_full_unstemmed | Efficacy and safety of febuxostat in elderly female patients |
| title_short | Efficacy and safety of febuxostat in elderly female patients |
| title_sort | efficacy and safety of febuxostat in elderly female patients |
| topic | febuxostat elderly female patients hyperuricemia |
| url | https://www.dovepress.com/efficacy-and-safety-of-febuxostat-in-elderly-female-patients-peer-reviewed-article-CIA |
| work_keys_str_mv | AT mizunot efficacyandsafetyoffebuxostatinelderlyfemalepatients AT hayashit efficacyandsafetyoffebuxostatinelderlyfemalepatients AT hikosakas efficacyandsafetyoffebuxostatinelderlyfemalepatients AT shimabukuroy efficacyandsafetyoffebuxostatinelderlyfemalepatients AT murasem efficacyandsafetyoffebuxostatinelderlyfemalepatients AT takahashik efficacyandsafetyoffebuxostatinelderlyfemalepatients AT hayashih efficacyandsafetyoffebuxostatinelderlyfemalepatients AT yuzaway efficacyandsafetyoffebuxostatinelderlyfemalepatients AT nagamatsut efficacyandsafetyoffebuxostatinelderlyfemalepatients AT yamadas efficacyandsafetyoffebuxostatinelderlyfemalepatients |